Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP930691.RAZF-62BllUxcCJ2SW21ak6nrw_FUkcSZOl4b-VGeI5wo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP930691.RAZF-62BllUxcCJ2SW21ak6nrw_FUkcSZOl4b-VGeI5wo130_assertion type Assertion NP930691.RAZF-62BllUxcCJ2SW21ak6nrw_FUkcSZOl4b-VGeI5wo130_head.
- NP930691.RAZF-62BllUxcCJ2SW21ak6nrw_FUkcSZOl4b-VGeI5wo130_assertion description "[Genomic amplification was detected in 26% and 23% of the ARMS and ERMS cases, respectively (with nearly all of the latter subset exhibiting anaplastic features).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930691.RAZF-62BllUxcCJ2SW21ak6nrw_FUkcSZOl4b-VGeI5wo130_provenance.
- NP930691.RAZF-62BllUxcCJ2SW21ak6nrw_FUkcSZOl4b-VGeI5wo130_assertion evidence source_evidence_literature NP930691.RAZF-62BllUxcCJ2SW21ak6nrw_FUkcSZOl4b-VGeI5wo130_provenance.
- NP930691.RAZF-62BllUxcCJ2SW21ak6nrw_FUkcSZOl4b-VGeI5wo130_assertion SIO_000772 11807989 NP930691.RAZF-62BllUxcCJ2SW21ak6nrw_FUkcSZOl4b-VGeI5wo130_provenance.
- NP930691.RAZF-62BllUxcCJ2SW21ak6nrw_FUkcSZOl4b-VGeI5wo130_assertion wasDerivedFrom befree-20150227 NP930691.RAZF-62BllUxcCJ2SW21ak6nrw_FUkcSZOl4b-VGeI5wo130_provenance.
- NP930691.RAZF-62BllUxcCJ2SW21ak6nrw_FUkcSZOl4b-VGeI5wo130_assertion wasGeneratedBy ECO_0000203 NP930691.RAZF-62BllUxcCJ2SW21ak6nrw_FUkcSZOl4b-VGeI5wo130_provenance.